Katherine Kwong, NP
Nurse Practitioner · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Katherine Kwong’s office at (408) 241-3801 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$4,994
Medicare paid this office $4,994 for 44 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 12 | $1,254 | $96 |
| Short return visit (20+ min) | 15 | $926 | $58 |
Who their Medicare patients are
44 Original Medicare patients in 2024. Average age 72 · 85 and older 0% · Women 66% · Health risk score 0.72. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 61% · Diabetes 34%.
The office billed $17,427, Medicare allowed $6,659 and paid $4,994; for 58 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 44 | 58 | 72 | 0.72 | $17,427 | $4,994 |
| 2023 | 37 | 50 | 69 | 0.76 | $14,070 | $4,719 |
| 2022 | 48 | 70 | 73 | 0.81 | $16,652 | $6,260 |
| 2021 | 45 | 70 | 72 | 0.99 | $14,524 | $5,837 |
| 2020 | 61 | 81 | 72 | 0.93 | $13,755 | $4,053 |
| 2019 | 60 | 97 | 71 | 1.45 | $20,062 | $4,774 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 15 | $1,793 | $100 |
| Short return visit (20+ min) | 16 | $1,096 | $68 |
2022: 2 services
| Short return visit (20+ min) | 21 | $1,808 | $79 |
| Return visit (30+ min) | 12 | $1,199 | $92 |
2021: 3 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,940 | $139 |
| Return visit (30+ min) | 16 | $1,460 | $86 |
| Short return visit (20+ min) | 18 | $1,303 | $65 |
2020: 3 services
| Short return visit (20+ min) | 22 | $1,248 | $54 |
| Return visit (30+ min) | 16 | $881 | $55 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $595 | $43 |
2019: 2 services
| Return visit (30+ min) | 28 | $2,486 | $80 |
| Short return visit (20+ min) | 33 | $2,019 | $55 |
Drugs they prescribed that Part D paid
$13,666
Pharmacies billed $13,666 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
110 generic and fewer than 11 brand-name prescriptions · $13,666 in drug cost · 22 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 18 | $86 | $5 |
| Alendronate | 13 | $75 | $6 |
Year by year
| 2024 | 131 | 58 | None | None | $13,666 |
| 2023 | 109 | 52 | None | None | $2,672 |
| 2022 | 152 | 66 | None | None | $4,535 |
| 2021 | 166 | 64 | 11% (18) | None | $3,108 |
| 2020 | 162 | 61 | 7% (12) | None | $5,133 |
| 2019 | 120 | 62 | None | None | $8,135 |
| 2018 | 82 | 34 | 0% (0) | None | $4,827 |
| 2017 | 114 | 54 | None | None | $6,661 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Ropinirole | 12 | $85 | $7 |
2022: 1 drug
| Irbesartan | 11 | $55 | $5 |
2021: 3 drugs
| Hydrocodone-Acetaminophen | 13 | $382 | $29 |
| Losartan | 11 | $203 | $18 |
| Cyclobenzaprine | 12 | $19 | $2 |
2020: 1 drug
| Omeprazole | 13 | $34 | $3 |
2017: 1 drug
| Levothyroxine | 11 | $153 | $14 |
Money from drug and device companies
$1,260 in 2025
| 2025 | 10 | 10 | None | $1,260 |
| 2024 | 10 | 10 | None | $1,249 |
| 2023 | 3 | 3 | None | $330 |
| 2022 | 3 | 3 | None | $358 |
| 2021 | 1 | 1 | None | $109 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Dexcom | Dexcom G7 Gss (161) | $145 | 1 payment
|
| Galderma Laboratories L.P. | Nemluvio | $140 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $137 | 1 payment
|
| Neurelis | Valtoco | $134 | 1 payment
|
| Gilead Sciences | None | $127 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $125 | 1 payment
|
See all 10 published payments
| Argenx US | Meals · 2025-11-11 | Vyvgart | $115 |
| Dexcom | Meals · 2025-09-27 | Dexcom G7 Gss (161) | $145 |
| Lilly USA | Meals · 2025-09-17 | Kisunla | $117 |
| Gilead Sciences | Meals · 2025-09-17 | None | $127 |
| Janssen Pharmaceuticals | Meals · 2025-06-27 | Spravato | $109 |
| Galderma Laboratories L.P. | Meals · 2025-05-13 | Nemluvio | $140 |
| Madrigal Pharmaceuticals | Meals · 2025-04-17 | Rezdiffra | $125 |
| Edwards Lifesciences | Meals · 2025-03-28 | Sapien 3 Ultra Resilia | $137 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-03-13 | None | $112 |
| Neurelis | Meals · 2025-01-15 | Valtoco | $134 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,249
| Sanofi-Aventis U.S. | Tzield | $150 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $150 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $136 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $125 | 1 payment
|
| Genzyme | Dupixent | $125 | 1 payment
|
| GlaxoSmithKline | Arexvy | $122 | 1 payment
|
| Mayne Pharma Commercial | Annovera | $122 | 1 payment
|
| Averitas Pharma | Qutenza | $122 | 1 payment
|
| Hologic Sales and Service | Aptima | $105 | 1 payment
|
| Biogen | Spinraza | $93 | 1 payment
|
2023: $330
| Gilead Sciences | Epclusa | $125 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $106 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $99 | 1 payment
|
2022: $358
| Amgen | Lumakras | $125 | 1 payment
|
| Abbvie | Vraylar | $125 | 1 payment
|
| Eisai | None | $108 | 1 payment
|
2021: $109
| Biohaven Pharmaceuticals | Nurtec Odt | $109 | 1 payment
|
Professional record
- NPI
- 1508240375
- Licence
- CA 95004373, NY 691574
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 2350 W El Camino Real Fl 2, Mountain View, CA, 94040
- NPI first listed
- 2015-07-11
- NPI last updated
- 2019-01-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 9460 N Name Uno Ste 110, Gilroy, CA, 95020